Friday, December 6, 2024

CATEGORY

Global Market Access

UK Diabetes Device Market Projects $2 Billion by 2032

Inferences:Government initiatives, particularly those supported by the NHS, are crucial in driving market growth. The aging population significantly contributes to the increasing demand...

Zimmer Biomet Introduces Persona® SoluTion™ PPS® Femur: A Cementless Total Knee Replacement Innovation

Key TakeawaysZimmer Biomet has received FDA clearance for the Persona® SoluTion™ PPS® Femur, a cementless knee replacement component designed for patients with bone...

EPF Welcomes New EU Commissioners, Pledges Partnership for Patient-Centered Health Care

Key TakeawaysEPF emphasizes the importance of maintaining patient health as a top priority in EU policies. Collaboration on pharmaceutical legislation and health technology...

WHO Endorses First Single-Dose Treatment for P. vivax Malaria

Key TakeawaysTafenoquine's approval accelerates malaria elimination efforts in multiple countries. The need for G6PD testing ensures safe administration, mitigating potential risks. Collaboration between...

Inari Medical Secures Reimbursement for ClotTriever in Japan

Key TakeawaysThe creation of a new functional category by MHLW underscores the ClotTriever's distinct clinical benefits. The partnership with Medikit is pivotal for...

Welsh Government Launches Comprehensive Hub on Sodium Valproate for Women

Welsh authorities have introduced a new dedicated platform aimed at providing extensive information on the use of sodium valproate among women and girls. This...

UK and South Korea Forge Alliance to Accelerate Clinical Trials

The United Kingdom and the Republic of Korea have embarked on a collaborative journey aimed at revolutionizing clinical trials. This partnership seeks to enhance...

Lundbeck Acquires Longboard to Strengthen Neuro-Rare Pipeline

Key TakeawaysLundbeck's acquisition enhances its position in the neuro-rare disease market, addressing unmet medical needs. Bexicaserin's advanced clinical development stage suggests a shorter...

Malaria Costs Nigeria Over $1.1 Billion Annually: Urgent Call for Elimination

Key TakeawaysNigeria loses over $1.1 billion annually due to malaria-related productivity losses and healthcare costs. Malaria accounts for 27% of global cases, with...

Cubecover: Revolutionizing Insurance for 10 Million Nigerians by 2027

Key TakeawaysCubecover aims to provide affordable insurance to 10 million Nigerians by 2027. The insuretech company leverages strategic partnerships and technology to enhance...

ACE Launches Educational Series on Health Technology and Funding in Singapore

ACE unveils a new suite of learning modules tailored for patients and the general public eager to delve into ACE's operational framework. These modules...

Biogen Japan Launches Innovative APOE Research Initiative

Biogen Japan has announced a groundbreaking research initiative focused on the APOE gene, a critical factor in Alzheimer's disease (AD) progression. Spearheaded by CEO...

Global Demand for Human Growth Hormones to Reach $10 Billion by 2030

Key TakeawaysIncreased prevalence of growth hormone deficiencies across age groups. Advancements in recombinant DNA technology enhancing treatment efficacy. Rise of biosimilars improving market...

Dr. Reddy’s and Senores Launch Generic Ivermectin to Enhance Market Competition

Dr. Reddy's Laboratories, in collaboration with Senores Pharmaceuticals, has introduced Ivermectin Tablets USP, 3 mg, into the U.S. market. This generic version mirrors Merck's...

Edwards Lifesciences’ SAPIEN 3 Ultra RESILIA Valve Shows Exceptional One-Year Outcomes

Edwards Lifesciences has unveiled promising one-year data for its latest SAPIEN 3 Ultra RESILIA valve at PCR London Valves 2024. The findings, also featured...

Latest news